Wein A J, Benson G S, Raezer D M, Mulholland S G
J Urol. 1976 Aug;116(2):140-1. doi: 10.1016/s0022-5347(17)58723-6.
Oral methylene blue therapy was not effective in dissolving non-obstructive renal calculi in 26 patients but it may prevent new stone formation in patients with metabolically active urolithiasis. The use of methylene blue therapy in combination with other regimens having different mechanisms of stone inhibition is recommended to further improve results.
口服亚甲蓝疗法对26例患者的非阻塞性肾结石溶解无效，但可能预防代谢活跃性尿路结石患者形成新结石。建议将亚甲蓝疗法与其他具有不同结石抑制机制的方案联合使用，以进一步提高疗效。
